Chemotherapy or radiotherapy for primary cancer prior to BM (P = 0.045), subtotal resection (P = 0.025), high expression of PDGFR-β (P = 0.044), and no adjuvant RT (P < 0.001) were significantly associated with shorter RFS. The gene discussed is PDGFRB; the disease is cancer.